This may be due to inhibitory cytokines such as TGF-β, IL-6 and IL-10 present in the MM microenvironment [16], [17], [18] or dysregulation of IL-15 signaling in favor of MM cells over activation of NK cells [19], [20]. The gene discussed is TGFB1; the disease is Miyoshi myopathy.